Twice-daily assessment of trekkers on Kilimanjaro's Machame route to evaluate the incidence and time-course of acute mountain sickness

High Altitude Medicine and Biology

Volumn 13, Issue 4, 2012, Pages 281-284

  Meyer, Joel ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

acute mountain sickness; incidence; Kilimanjaro

Indexed keywords

ACETAZOLAMIDE; DEXAMETHASONE;

ACUTE DISEASE; ADULT; AGED; ALTITUDE ACCLIMATIZATION; ALTITUDE DISEASE; ARTICLE; BRAIN EDEMA; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MORBIDITY; MOUNTAINEERING; PRIORITY JOURNAL; PROPHYLAXIS; SCORING SYSTEM; SYMPTOM ASSESSMENT;

ACCLIMATIZATION; ACUTE DISEASE; ADULT; AGED; ALTITUDE SICKNESS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MOUNTAINEERING; SEVERITY OF ILLNESS INDEX; SLEEP; TANZANIA; TIME FACTORS;

EID: 84876347037     PISSN: 15270297     EISSN: 15578682     Source Type: Journal    
DOI: 10.1089/ham.2012.1024     Document Type: Article

References (19)

1. Basnyat B, Gertsch JH, Johnson EW, Castro-Marin F, Inoue Y, and Yeh C. (2003). Efficacy of low-dose acetazolamide (125mg BID) for the prophylaxis of acute mountain sickness: A prospective, double-blind, randomized, placebo-controlled trial. High Alt Med Biol 4:45-52. (Pubitemid 36511798)
2. Basnyat B, Lemaster J, and Litch JA. (1999). Everest or bust: A cross sectional, epidemiological study of acute mountain sickness at 4243 meters in the Himalayas. Aviat Space Environ Med 70:867-873. (Pubitemid 29533419)
3. Bloch KE, Turk AJ, Maggiorini M, Hess T, Merz T, Bosch MM, Barthelmes D, Hefti U, Pichler J, Senn O, and Schoch OD. (2009). Effect of ascent protocol on acute mountain sickness and success at Muztagh Ata, 7546 m. High Alt Med Biol 10: 25-32.
4. Daniels R. (2012). Pulse oximetry after 6-minute walk test and summit success on Kilimanjaro. Wilderness Environ Med 23:95-96.
5. Davies AJ, Kalson NS, Stokes S, Earl MD, Whitehead AG, Frost H, Tyrell-Marsh I, and Naylor J. (2009). Determinants of summiting success and acute mountain sickness on Mt Kilimanjaro (5895m). Wilderness Environ Med 20: 311-317.
6. Gallagher SA and Hackett PH. (2004). High-altitude illness. Emerg Med Clin North Am 22:329-355, viii. (Pubitemid 38686295)
7. Hauser M, Mueller A, Swai B, Moshi E, and Ole N. S. (2004). Deaths due to high altitude illness among tourists climbing Mt Kilimanjaro. Proceedings of the 2004 South African Travel Medicine Society Feb 9-11 2004 Cape Town http://www.sastm.org.za/articles/AECTM-Abstracts.pdf accessed 5 March 2012.
8. Jackson SJ, Varley J, Sellers C, Josephs K, Codrington L, Duke G, Njelekela MA, Drummond G, Sutherland AI, Thompson AA, and Baillie JK. (2010). Incidence and predictors of acute mountain sickness among trekkers on Mount Kilimanjaro. High Alt Med Biol 11:217-222.
9. Kalson NS, Thompson J, Davies AJ, Stokes S, Earl MD, Whitehead A, Tyrrell-Marsh I, Frost H, and Montgomery H. (2009). The effect of angiotensin-converting enzyme genotype on acute mountain sickness and summit success in trekkers attempting the summit of Mt. Kilimanjaro (5895 m). Eur J Appl Physiol 105:373-379.
10. Karinen H, Peltonen J, and Tikkanen H. (2008). Prevalence of acute mountain sickness among Finnish trekkers on Mount Kilimanjaro, Tanzania: An observational study. High Alt Med Biol 9:301-306.
11. Kayser B, Hulsebosch R, and Bosch F. (2008). Low-dose acetylsalicylic acid analog and acetazolamide for prevention of acute mountain sickness. High Alt Med Biol 9:15-23. (Pubitemid 351363932)
12. Luks AM, McIntosh SE, Grissom CK, Auerbach PS, Rodway GW, Schoene RB, Zafren K, and Hackett PH. (2010).Wilderness Medical Society consensus guidelines for the prevention and treatment of acute altitude illness. Wilderness Environ Med 21:146-155.
13. Mackie S and Windsor JS. (2009). Is there a safer and more successful way to climb Kilimanjaro? High Alt Med Biol 10: 301-32; author reply 303.
14. Maggiorini M, Muller A, Hofstetter D, Bartsch P, and Oelz O. (1998). Assessment of acute mountain sickness by different score protocols in the Swiss Alps. Aviat Space Environ Med 69:1186-1192. (Pubitemid 28544217)
15. Roach RC, Bartsch P, Hackett PH, Oelz O, and The Lake Louise AMS Scoring Consensus Committee (1993). The Lake Louise acute mountain sickness scoring system. In: Sutton JR, Coates G, Huston CS, eds. Hypoxia and Molecular Medicine: Proceedings of the 8th international hypoxia symposium, 9-13 Feb, 1993; Lake Louise, Alberta, Canada. Burlington, VT: Queen City Printers, 1993:272-274.
16. Shah NM, Windsor JS, Meijer H, and Hillebrandt D. (2011). Are UK commercial expeditions complying with wilderness medical society guidelines on ascent rates to altitude? J Travel Med 18:214-216.
17. Singh I, Khanna PK, Srivastava MC, Lal M, Roy SB, and Subramanyam CS. (1969). Acute mountain sickness. N Engl J Med 280:175-184.
18. Stokes S, Kalson N, Earl M, Frost H, Whitehead AG, Tyrrell- Marsh I, and Davies A. (2008). Bronchial asthma on Mount Kilimanjaro is not a disadvantage. Thorax 63:936-937.
19. Vardy J and Judge K. (2005). Can knowledge protect against acute mountain sickness? J Public Health (Oxf) 27:366-370. (Pubitemid 41752471)